Vertudazo, Anita .
HRN: 51-89-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFTAZIDIME 1GM (VIAL)
09/18/2022
09/23/2022
IV
2g
Q8h
Ascending Cholangitis, Cholelithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes